Literature DB >> 9061570

Mutation prevalence among 47 unrelated Japanese patients with Gaucher disease: identification of four novel mutations.

H Ida1, O M Rennert, H Kawame, K Maekawa, Y Eto.   

Abstract

Utilizing PCR and PCR-SSCP analysis we investigated the prevalence of glucocerebrosidase gene mutations in 47 unrelated Japanese patients with Gaucher disease. Sixty alleles (63.8%) and 20 alleles (21.3%) were identified by analysis for common mutations and PCR-SSCP analysis, respectively. The L444P and F213I mutations were common, accounting for 41 alleles (43.6%) and 14 alleles (14.9%). R496C, D409H, S366G and 1447-1466 del ins TG mutations were identified in 5, 3, 3 and 3 alleles, respectively. The other mutations were unique. In spite of vigorous screening, 14 alleles (14.9%) could not be identified. Four novel mutations were identified by PCR-SSCP analysis: G189V, S366G, K413Q and R433G. These data indicate that besides the L444P mutation no other frequent mutation is present and there is broad heterogeneity of the glucocerebrosidase gene mutations in Japanese patients with Gaucher disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9061570     DOI: 10.1023/a:1005313724361

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  15 in total

Review 1.  Gaucher disease.

Authors:  D Balicki; E Beutler
Journal:  Medicine (Baltimore)       Date:  1995-11       Impact factor: 1.889

Review 2.  Gaucher disease: new molecular approaches to diagnosis and treatment.

Authors:  E Beutler
Journal:  Science       Date:  1992-05-08       Impact factor: 47.728

3.  Identification of six new Gaucher disease mutations.

Authors:  E Beutler; T Gelbart; C West
Journal:  Genomics       Date:  1993-01       Impact factor: 5.736

4.  Gaucher disease mutations in non-Jewish patients.

Authors:  E Beutler; T Gelbart
Journal:  Br J Haematol       Date:  1993-10       Impact factor: 6.998

5.  Use of denaturing gradient gel electrophoresis to identify mutant sequences in the beta-glucocerebrosidase gene.

Authors:  K H Laubscher; R H Glew; R E Lee; R T Okinaka
Journal:  Hum Mutat       Date:  1994       Impact factor: 4.878

6.  Prevalence of nine mutations among Jewish and non-Jewish Gaucher disease patients.

Authors:  M Horowitz; G Tzuri; N Eyal; A Berebi; E H Kolodny; R O Brady; N W Barton; A Abrahamov; A Zimran
Journal:  Am J Hum Genet       Date:  1993-10       Impact factor: 11.025

7.  Rapid identification of mutations in the glucocerebrosidase gene of Gaucher disease patients by analysis of single-strand conformation polymorphisms.

Authors:  H Kawame; Y Hasegawa; Y Eto; K Maekawa
Journal:  Hum Genet       Date:  1992-11       Impact factor: 4.132

8.  Five new Gaucher disease mutations.

Authors:  E Beutler; T Gelbart; A Demina; A Zimran; P LeCoutre
Journal:  Blood Cells Mol Dis       Date:  1995       Impact factor: 3.039

Review 9.  Mutations causing Gaucher disease.

Authors:  M Horowitz; A Zimran
Journal:  Hum Mutat       Date:  1994       Impact factor: 4.878

10.  Phenotype/genotype correlations in Gaucher disease type I: clinical and therapeutic implications.

Authors:  A Sibille; C M Eng; S J Kim; G Pastores; G A Grabowski
Journal:  Am J Hum Genet       Date:  1993-06       Impact factor: 11.025

View more
  12 in total

1.  Prevalence of arylsulphatase A mutations in 11 Japanese patients with metachromatic leukodystrophy: identification of two novel mutations.

Authors:  K Kurosawa; H Ida; Y Eto
Journal:  J Inherit Metab Dis       Date:  1998-10       Impact factor: 4.982

2.  Successful treatment of Gaucher disease type 1 by enzyme replacement therapy over a 10-year duration in a Japanese pediatric patient: A case report.

Authors:  Yuji Oto; Takeshi Inoue; So Nagai; Shinichiro Tanaka; Hisashi Itabashi; Masahisa Shiraisihi; Akihisa Nitta; Nobuyuki Murakami; Hiroyuki Ida; Tomoyo Matsubara
Journal:  Exp Ther Med       Date:  2021-01-22       Impact factor: 2.447

3.  Severe skeletal complications in Japanese patients with type 1 Gaucher disease.

Authors:  H Ida; O M Rennert; S Kato; T Ueda; K Oishi; K Maekawa; Y Eto
Journal:  J Inherit Metab Dis       Date:  1999-02       Impact factor: 4.982

4.  Improvement of splenomegaly and pancytopenia by enzyme replacement therapy against type 1 Gaucher disease: a report of sibling cases.

Authors:  K Tsuboi; S Iida; M Kato; Y Hayami; I Hanamura; K Miura; S Harada; H Komatsu; S Banno; A Wakita; M Nitta; R Ueda
Journal:  Int J Hematol       Date:  2001-04       Impact factor: 2.490

5.  Clinical and molecular characteristics of Japanese Gaucher disease.

Authors:  Y Eto; H Ida
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

6.  Mapping the genetic and clinical characteristics of Gaucher disease in the Iberian Peninsula.

Authors:  Pilar Giraldo; Pilar Alfonso; Pilar Irún; Laura Gort; Amparo Chabás; Lluïsa Vilageliu; Daniel Grinberg; Clara M Sá Miranda; Miguel Pocovi
Journal:  Orphanet J Rare Dis       Date:  2012-03-19       Impact factor: 4.123

7.  Genetic and clinical characteristics of Filipino patients with Gaucher disease.

Authors:  Mary Anne D Chiong; Marie Julianne C Racoma; Mary Ann R Abacan
Journal:  Mol Genet Metab Rep       Date:  2018-04-05

8.  A novel mutation causing type 1 Gaucher disease found in a Japanese patient with gastric cancer: A case report.

Authors:  Sakura Hosoba; Katsuyuki Kito; Yukako Teramoto; Kaori Adachi; Ryota Nakanishi; Ai Asai; Masaki Iwasa; Rie Nishimura; Suzuko Moritani; Masahiro Kawahara; Hitoshi Minamiguchi; Eiji Nanba; Ryoji Kushima; Akira Andoh
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

9.  Screening for Gaucher Disease Using Dried Blood Spot Tests: A Japanese Multicenter, Cross-sectional Survey.

Authors:  Toshihiro Miyamoto; Masaki Iino; Yasuji Komorizono; Toru Kiguchi; Nobufusa Furukawa; Maki Otsuka; Shohei Sawada; Yutaka Okamoto; Kenji Yamauchi; Toshitaka Muto; Tomoaki Fujisaki; Hisashi Tsurumi; Kimitoshi Nakamura
Journal:  Intern Med       Date:  2021-03-01       Impact factor: 1.271

10.  Gaucher disease: Biochemical and molecular findings in 141 patients diagnosed in Greece.

Authors:  Evangelia Dimitriou; Marina Moraitou; Mónica Cozar; Jenny Serra-Vinardell; Lluïsa Vilageliu; Daniel Grinberg; Irene Mavridou; Helen Michelakakis
Journal:  Mol Genet Metab Rep       Date:  2020-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.